CM Bhupendra Patel inaugurates HAEMATOCON 2026 in Ahmedabad
Synopsis
Key Takeaways
A national gathering of blood specialists opened in Ahmedabad on Saturday, 14 November 2026, as Chief Minister Bhupendra Patel inaugurated the 67th Annual Conference of the Indian Society of Haematology and Blood Transfusion — branded HAEMATOCON 2026 — marking one of India's premier medical forums for haematology and transfusion medicine.
What CM Patel said at the inaugural
Addressing the gathering, CM Patel framed the conference as a platform that would give 'new direction' to Prime Minister Narendra Modi's resolve to build a Viksit Bharat (Developed India) through the creation of a healthy society. He described HAEMATOCON 2026 as a convergence of 'knowledge, science, and research for the protection of human life' — a formulation that positioned the annual academic event within the broader national development narrative. The Chief Minister also unveiled the organisation's souvenir at the ceremony, a customary gesture at major professional conclaves.
HAEMATOCON 2026 and the ISHBT's role in Indian medicine
The Indian Society of Haematology and Blood Transfusion (ISHBT) is the country's apex professional body for specialists working in blood disorders and transfusion science. Its annual conference rotates across Indian cities, drawing haematologists, oncologists, and clinical researchers to exchange findings on conditions ranging from thalassaemia and sickle-cell disease to leukaemia and bleeding disorders. Hosting the 67th edition in Ahmedabad continues Gujarat's recent pattern of anchoring national-level health and scientific meetings — a pattern state officials have linked to improving research infrastructure.
Health policy backdrop: Ayushman Bharat to Viksit Bharat
The inauguration lands against a well-established policy arc. The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana, launched in 2018, extended health coverage to low-income families and brought specialised care — including haematological conditions — within the ambit of public health financing. The National Health Policy of 2017 had earlier set the direction, emphasising universal access, preventive care, and investment in medical research. CM Patel's remarks at the conference explicitly connected these threads to the Viksit Bharat target of a fully developed India by 2047.
For the haematology community, the political attention is more than ceremonial. Specialised conferences that receive state-level patronage often find it easier to attract research funding, clinical trial participation, and inter-institutional collaboration — outcomes that can translate into updated clinical guidelines and improved patient outcomes for the millions of Indians living with blood disorders.
Whether HAEMATOCON 2026 produces landmark research declarations or new state health commitments will become clear in the sessions ahead — but the signal from Gandhinagar is unambiguous: Gujarat is positioning itself as a node in India's medical-research ambitions.